214 related articles for article (PubMed ID: 12783426)
21. Augmentation of Endogenous Acetylcholine Uptake and Cholinergic Facilitation of Hippocampal Long-Term Potentiation by Acetylcholinesterase Inhibition.
Masuoka T; Uwada J; Kudo M; Yoshiki H; Yamashita Y; Taniguchi T; Nishio M; Ishibashi T; Muramatsu I
Neuroscience; 2019 Apr; 404():39-47. PubMed ID: 30708046
[TBL] [Abstract][Full Text] [Related]
22. The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.
Andersen MB; Werge T; Fink-Jensen A
J Pharmacol Exp Ther; 2007 Jun; 321(3):1179-82. PubMed ID: 17374745
[TBL] [Abstract][Full Text] [Related]
23. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
24. Dysfunction of muscarinic acetylcholine receptors as a substantial basis for progressive neurological deterioration in GM3-only mice.
Tajima O; Egashira N; Ohmi Y; Fukue Y; Mishima K; Iwasaki K; Fujiwara M; Sugiura Y; Furukawa K; Furukawa K
Behav Brain Res; 2010 Jan; 206(1):101-8. PubMed ID: 19744524
[TBL] [Abstract][Full Text] [Related]
25. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
Luques L; Shoham S; Weinstock M
Exp Neurol; 2007 Aug; 206(2):209-19. PubMed ID: 17580085
[TBL] [Abstract][Full Text] [Related]
26. Interaction of interleukin-1beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells.
Schliebs R; Heidel K; Apelt J; Gniezdzinska M; Kirazov L; Szutowicz A
Brain Res; 2006 Nov; 1122(1):78-85. PubMed ID: 17026971
[TBL] [Abstract][Full Text] [Related]
27. Heavy metal uranium affects the brain cholinergic system in rat following sub-chronic and chronic exposure.
Bensoussan H; Grancolas L; Dhieux-Lestaevel B; Delissen O; Vacher CM; Dublineau I; Voisin P; Gourmelon P; Taouis M; Lestaevel P
Toxicology; 2009 Jun; 261(1-2):59-67. PubMed ID: 19409444
[TBL] [Abstract][Full Text] [Related]
28. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
[TBL] [Abstract][Full Text] [Related]
29. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice.
Gautam D; Heard TS; Cui Y; Miller G; Bloodworth L; Wess J
Mol Pharmacol; 2004 Aug; 66(2):260-7. PubMed ID: 15266016
[TBL] [Abstract][Full Text] [Related]
30. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
[TBL] [Abstract][Full Text] [Related]
31. Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice.
Li B; Duysen EG; Volpicelli-Daley LA; Levey AI; Lockridge O
Pharmacol Biochem Behav; 2003 Mar; 74(4):977-86. PubMed ID: 12667913
[TBL] [Abstract][Full Text] [Related]
32. The effects of some porphyrinogenic drugs on the brain cholinergic system.
Rodriguez JA; Buzaleh AM; Fossati M; Azcurra J; Batlle AM
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):103-10. PubMed ID: 11929041
[TBL] [Abstract][Full Text] [Related]
33. Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus.
Anisuzzaman AS; Uwada J; Masuoka T; Yoshiki H; Nishio M; Ikegaya Y; Takahashi N; Matsuki N; Fujibayashi Y; Yonekura Y; Momiyama T; Muramatsu I
J Neurochem; 2013 Aug; 126(3):360-71. PubMed ID: 23678982
[TBL] [Abstract][Full Text] [Related]
34. Control of glycinergic input to spinal dorsal horn neurons by distinct muscarinic receptor subtypes revealed using knockout mice.
Zhang HM; Zhou HY; Chen SR; Gautam D; Wess J; Pan HL
J Pharmacol Exp Ther; 2007 Dec; 323(3):963-71. PubMed ID: 17878406
[TBL] [Abstract][Full Text] [Related]
35. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.
Farchi N; Shoham S; Hochner B; Soreq H
Eur J Neurosci; 2007 Jan; 25(1):87-98. PubMed ID: 17241270
[TBL] [Abstract][Full Text] [Related]
36. Evoked slow muscarinic acetylcholinergic synaptic potentials in rat hippocampal interneurons.
Widmer H; Ferrigan L; Davies CH; Cobb SR
Hippocampus; 2006; 16(7):617-28. PubMed ID: 16770798
[TBL] [Abstract][Full Text] [Related]
37. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice.
Adler M; Manley HA; Purcell AL; Deshpande SS; Hamilton TA; Kan RK; Oyler G; Lockridge O; Duysen EG; Sheridan RE
Muscle Nerve; 2004 Sep; 30(3):317-27. PubMed ID: 15318343
[TBL] [Abstract][Full Text] [Related]
38. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
[TBL] [Abstract][Full Text] [Related]
39. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.
Mulder J; Harkany T; Czollner K; Cremers TI; Keijser JN; Nyakas C; Luiten PG
Behav Brain Res; 2005 Aug; 163(1):33-41. PubMed ID: 15951032
[TBL] [Abstract][Full Text] [Related]
40. Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase.
Svedberg MM; Bednar I; Nordberg A
Neuropharmacology; 2004 Sep; 47(4):558-71. PubMed ID: 15380373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
